Anthem gets $26.5B funding commitment for Cigna takeover
Anthem Inc.’s bid to become the largest health insurer in history is setting up one of the biggest debt offerings backing a takeover.
Health Care
Articles
Health insurer deal fever may spread to hospitals next
Seeing mergers like Anthem’s planned acquisition of Cigna Corp., hospitals could decide that striking deals of their own could improve their negotiating power over medical reimbursements.
City dodges bullet as HQ stays under Anthem-Cigna deal
The company says its corporate headquarters will remain in Indianapolis, where its operations are responsible for contributing millions of dollars in corporate taxes and charitable giving.
VA secretary optimistic Congress will plug budget gap
During a visit to the Richard L. Roudebush VA Medical Center in Indianapolis, Robert McDonald said Thursday he thinks Congress will act to avoid shutting down some VA hospitals and other cost-cutting steps.
Anthem to buy Cigna in $54B deal
After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.
Anthem’s next challenge: getting regulators to say OK
The next challenge for Anthem Inc. in its quest to marry Cigna Corp. is to get its legal guardians to allow the ceremony to happen.
Indy’s top 11 acquisition deals, before Anthem-Cigna
Anthem’s $54 billion bid for rival insurer Cigna is twice the size of the next-largest acquisition in the Indianapolis area, which occurred nearly a decade ago.
Lilly posts lackluster profit but boosts full-year forecast
Eli Lilly and Co.’s profits plunged 18 percent in the second-quarter but still easily beat the lowered expectations of Wall Street analysts.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Study shows Lilly’s Alzheimer’s drug has small but lasting benefit
New data released Wednesday morning suggest that Eli Lilly and Co.’s Alzheimer’s drug has a modest but lasting impact on the memory-sapping disease. But analysts worry the impact is too small to be meaningful.
Indy-area woman charged with faking nursing license, cancer
Ashley Trent faces charges of forgery, deception, theft and practicing nursing without a license. She also is accused of forging letters from IU Health that claimed she had breast cancer.
Report ranks Indiana 32nd for child well-being
The national report found that more Indiana children have health insurance and fewer are abusing drugs and alcohol, but the state still dropped in the rankings due to improved results in other states.
Indy-based health data firm snares $1.5M in VC round
Healthiest Employers LLC, which collects and measures corporate health information, plans to use the funds to drive sales of its analytics software.
Cook Pharmica to hire 70 workers to expand drug-making capacity
Cook Pharmica, a subsidiary of Bloomington-based medical device maker Cook Group, currently employs 575 workers who manufacture and package drugs for use in clinical trials or for sale on the market.
St. Vincent to dangle health insurance deal to employers
The hospital system and a partner company have started meeting with health insurance brokers to pitch a program to save employers money by keeping workers and their families healthier.
UPDATE: Pence, other governors order Planned Parenthood probes
Gov. Mike Pence has directed the Indiana Department of Health to investigate whether organs from aborted fetuses are being sold.
Lilly partner Immunocore raises record $320 million
Immunocore Ltd., which this week achieved the biggest private fundraising by a European biotechnology firm in 10 years, plans to accelerate development of its cancer therapy using the money and seek expedited approval.
FAST 25: Mainstreet
When you have a health care business for which “there’s a tremendous need and virtually no product”—which Mainstreet founder and CEO Zeke Turner said is what his company has—growth potential would seem unlimited.
Health care industry: Healthy Indiana Plan working smoothly
State enrollment in HIP 2.0 has climbed to nearly 290,000 participants, with about 60 percent of those people under age 40, according to state figures presented Thursday.
Lilly, partner sue Lupin over generic testosterone
Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.